Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · TransMedics Group (TMDX)

TransMedics buys 22nd aircraft for $14.5 million for National OCS Program

Neutral Impact 2 of 5 m&a Written later

TransMedics, Inc., a wholly-owned subsidiary of TransMedics Group, Inc., bought one fixed-wing aircraft from Teaghlach Aviation, LLC on October 3, 2025, for approximately $14.5 million. The company says it now has 22 aircraft in total and plans to use them to transport donor organs under its National OCS Program. The filing describes this as an incremental addition to a fleet built through earlier acquisitions.

Key points

  • Purchase date: October 3, 2025, from Teaghlach Aviation, LLC
  • Purchase price: approximately $14.5 million
  • Total aircraft acquired to date: 22 (21 in prior acquisitions plus this one)
  • Stated use: transporting donor organs as part of the National OCS Program

The filing

CompanyTransMedics Group (TMDX)
Form8-K, current report
Filed with the SECOct 6, 2025, 4:15 PM ET
Accession number0001193125-25-231900

Items reported: 2.01 Acquisition or Disposition Completed

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:49 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 06, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.